Published on

The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results.

AACC guidance on the management of point-of-care testing

en

American Association for Clinical Chemistry (AACC) Academy, 2020

American Association for Clinical Chemistry (AACC) Academy (formerly known as the National Academy of Clinical Biochemistry, NACB) discusses how point-of-care testing (POCT) is a now proven approach that can provide faster turnaround of laboratory test results. The authors highlight that as manufacturers continue to introduce new POCT technologies, POCT is increasing in popularity, breadth of testing, and in the diversity of available clinical applications.

The guideline focusses on how clinicians can get the most efficacy and highest quality results from implementing best practices for POCT. The authors state that a quality assurance program is vital to managing reliability of POCT results. The guidance focusses on:

  • The value of an interdisciplinary committee to oversee POCT
  • Education to improve POCT performance
  • Optimal staffing models for POCT
  • Proficiency testing (PT)/external quality assessment (EQA) programs to improve POCT performance and patient outcomes
  • Data management to improve POCT outcomes
  • Staff selection of POCT devices
  • POCT to improve process

Overall, the authors provide guidance to the laboratory, to clinicians, and to operators in how to best adopt POCT in their setting to optimise patient care.

The full publication can be accessed here.

COL-08879 10/2021

Related News

Cards

  • Published on

    Kunihiro Matsushita, Josef Coresh, Yingying Sang, John Chalmers, Caroline Fox, Eliseo Guallar, Tazeen Jafar, Simerjot K Jassal, Gijs W D Landman, Paul Muntner, Paul Roderick, Toshimi Sairenchi, Ben Schöttker, Anoop Shankar, Michael Shlipak, Marcello Tonelli, Jonathan Townend, Arjan van Zuilen, Kazumasa Yamagishi, Kentaro Yamashita, Ron Gansevoort, Mark Sarnak, David G Warnock, Mark Woodward, Johan Ärnlöv, CKD Prognosis Consortium

    Estimated glomerular filtration rate and albumin-to-creatinine ratio testing for cardiovascular risk assessment

    en
    Access Now
    Restricted
  • Published on

    Johan Sundström, Johan Bodegard, Andreas Bollmann, Marc G Vervloet, Patrick B Mark, Avraham Karasik, Tiago Taveira-Gomes, Manuel Botana, Kåre I Birkeland, Marcus Thuresson, Levy Jäger, Manish M Sood, Gijs VanPottelbergh, Navdeep Tangri; on behalf of the CaReMe CKD Investigators

    Prevalence, outcomes and cost of chronic kidney disease

    en
    Access Now
    Restricted
  • Published on

    Marleen Smits, Rogier Hopstaken, Lusan Terhaag, Gijs de Kort, Paul Giesen

    HbA1c and glucose point‑of‑care testing in general practice

    en
    Access Now
    Restricted